← Back to news
Research & studiesEurope PMC·Jul 8, 2026
Biomarker screen-guided care for preterm birth risk in nulliparous pregnancies: a subgroup analysis of the PRIME randomized controlled trial.
By Sciscione AC, Gyamfi-Bannerman C, Walker M, Shahbaba B, Godt J, Iriye BK.
im; multicenter study; randomized controlled trial; journal article · J Matern Fetal Neonatal Med (2026)
This headline was gathered automatically from a public feed. I AM GRACE does not host the full article — you will be taken to the original publisher.